Aridis: Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
Aridis Pharmaceuticals, Inc. (OTCQB: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today reported financial and corporate results for its third quarter ended September 30, 2023.
Read full article »
Aridis is a California-based biopharmaceutical company that discovers and develops novel anti-infective therapies for the treatment of respiratory infections.
Read more